-
Regardless of whether they realize it, case managers have likely worked with patients who are living with Alzheimer’s disease or dementia. The diagnosis rate is relatively low. Even when a formal diagnosis is made, treatment is not necessarily offered — and for many patients, the diagnosis largely is overlooked.
-
As the pandemic continues, some healthcare facilities worldwide are providing acute care to patients in their homes. This is a necessity in places where the health systems have been overwhelmed. In other places, it is a way to provide care that might even be safer for certain medically stable patients.
-
Patients who received ICU care experience problems that need to be resolved before they are discharged. These can include delirium, debility, and dysphagia, researchers say.
-
Emerging data and reports suggest long-term stress and burnout among nurses has escalated since the COVID-19 pandemic began — which might contribute to increasing numbers of nurses leaving the workforce.
-
Cyberattacks have targeted 911 dispatchers, emergency medical services over the past year.
-
Juggling the work of an IRB of record and becoming a relying IRB can be challenging. But one underlying goal can keep an IRB on track with both roles: consistency.
-
Whether institutions are the IRB of record or the relying IRB, setting up a seamless process involves many time-consuming processes — and it can take years. One of the obstacles to an efficient IRB reliance effort is handling the technological details.
-
It is unlikely IRBs will see many studies with one enrolled participant (the N=1 study design), but they should be prepared for this type of protocol. The single-subject study design can be applied to chronic conditions like cystic fibrosis or to ultra-rare diseases.
-
One hot topic during a recent webinar on diversity in clinical trials centered around whether researchers should use race in a clinical trial. Using race as a variable is never neutral and never scientific, one expert noted.
-
Structural racism is a powerful construct that may influence participation in clinical research studies, panelists of a recent webinar noted.
